Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University
MSC-exo Technology Has Potential to Treat Autism Using Novel Intranasal Administration Preclinical Studies Have Demonstrated a Benefit on Core Autism Symptoms JERUSALEM Israel, January 2nd,
Human Muscle Progenitor Cells Ectopically Expressing Neurotrophic Factors to Enhance Intrinsic Neuronal Regeneration
Stem Cell Medicine Ltd. (SCM), will present the results of a study titled “Human Muscle Progenitor Cells Ectopically Expressing Neurotrophic Factors Enhance Intrinsic Neuronal Regeneration in a Sciatic Nerve Injury Mouse Model”.
Stem Cell Medicine Signs License and Research Agreement with Ramot and Yeda to Develop Stem Cell-Based Treatments for Neuronal Diseases
Jerusalem, Israel, December 2, 2015 — Stem Cell Medicine Ltd. (SCM), Ramot at Tel Aviv University Ltd. (Ramot), and Yeda Research and Development Company Ltd. (YEDA), announced today that they have entered into a license and research funding agreement…